Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

59.88
-0.4800-0.80%
Post-market: 59.880.00000.00%19:30 EDT
Volume:1.87M
Turnover:112.59M
Market Cap:9.95B
PE:-17.21
High:60.99
Open:60.37
Low:59.78
Close:60.36
52wk High:86.74
52wk Low:49.13
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.93
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:22.63
PE(LYR):-25.15

Loading ...

How Olezarsen’s Longer-Term Hepatic Data and High Retention Could Shape Ionis Pharmaceuticals (IONS) Investors

Simply Wall St.
·
Jun 20

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

InvestorPlace
·
Jun 19

Ionis Pharmaceuticals Is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jun 17

U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower

Reuters
·
Jun 17

Ionis director Spencer R. Berthelsen sells 8,000 shares worth $587,920

Reuters
·
Jun 17

Jefferies Remains a Buy on Ionis Pharmaceuticals (IONS)

TIPRANKS
·
Jun 15

Ionis posts presentation on olezarsen-triglyceride reductions in severe hypertriglyceridemia

Reuters
·
Jun 15

Ionis posts ENDO 2026 presentation on olezarsen pancreatitis prevention in severe hypertriglyceridemia

Reuters
·
Jun 15

Ionis posts CORE-TIMI severe hypertriglyceridemia olezarsen data presentation

Reuters
·
Jun 13

Ionis shares 24-month extension data on olezarsen in severe hypertriglyceridemia study

Reuters
·
Jun 13

Fonds de solidarité FTQ joins $20 million CELYSTRA Pharma financing round

Reuters
·
Jun 09

Ionis Pharmaceuticals director Peter N. Reikes files initial beneficial ownership statement

Reuters
·
Jun 09

Ionis Pharmaceuticals Adds Veteran Leader to Board

TIPRANKS
·
Jun 09

Ionis adds former Alexion CEO Ludwig Hantson to board

Reuters
·
Jun 09

BRIEF-Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors

Reuters
·
Jun 08

Ionis Announces Appointment of Ludwig Hantson, Ph.d. to Board of Directors

THOMSON REUTERS
·
Jun 08

Ionis Pharmaceuticals (IONS) Receives a Buy from Guggenheim

TIPRANKS
·
Jun 06

Ionis posts presentation for 2026 annual shareholders meeting

Reuters
·
Jun 05

Ionis director Spencer R. Berthelsen disposes of 8,000 common shares for $605,360

Reuters
·
Jun 04

Ionis Pharmaceuticals Price Target Maintained With a $125.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 01